Prostate Cancer Research: Importance of Clinical Trials

0
(0)

Clinical trials are of great importance in the medical field. They are required by the U.S. Food and Drug Administration (FDA) before approving new medical therapies for patients with prostate cancer, and they are also determinant to increase knowledge about the disease. This video from TrialReach highlights the role clinical trials play in the fight against prostate cancer.

“About 1 in 7 men will get prostate cancer during his lifetime. It’s the second most frequently diagnosed cancer globally and it will cause nearly 30,000 deaths this year. Researchers are looking for better treatments and for patients to take part in studies,” explains the video published on the Youtube channel of TrialReach, a free online platform that’s transforming the way patients find and match to clinical trials.

“If you have received a prostate cancer diagnosis, you may be eligible to take part,” it continues. “What starts with you answering a few questions could end with a cure.” Clinical trials are not only important for science, but for patients as well, since they are ways to find new and more effective treatments for prostate cancer. In addition, patients can be granted assess to investigational medical treatments, and receive other benefits such as reduced cost or free health care.

 

Find out more about prostate cancer clinical trials: http://bit.ly/1TBQgHE

Learn more about prostate cancer: http://bit.ly/1MlKABv

Prostate Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • NCCN and Rubraca
  • Orgovyx and FDA approval
  • Lynparza
  • Erleada results

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *